Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study

Figure 2

Mean frequency scale for the symptoms of gastroesophageal reflux disease (FSSG) scores in the two groups before and after treatment. The FSSG scores, which included the reflux- and dysmotility-related scores, significantly improved in both groups after H. pylori eradication, but no significant intergroup differences were observed. Compared with baseline (rebamipide group). Compared with baseline (untreated group). Rebamipide versus untreated group.